Navigation Links
FDA Approves Zytiga for Late-Stage Prostate Cancer
Date:4/28/2011

a placebo (sugar pill) twice daily in combination with prednisone.

The study was designed to measure overall survival, the length of time from when the treatment started until a patient's death. Patients who received the Zytiga and prednisone combination had a median overall survival of 14.8 months compared to 10.9 months for patients receiving the placebo and prednisone combination.

The most commonly reported side effects in patients receiving Zytiga included joint swelling or discomfort, low levels of potassium in the blood, fluid retention (usually of the legs and feet), muscle discomfort, hot flashes, diarrhea, urinary tract infection, cough, high blood pressure, heartbeat disorders, urinary frequency, increased nighttime urination, upset stomach or indigestion and upper respiratory tract infection.

Zytiga is marketed by Horsham, Pa.-based Centocor Ortho Biotech, Inc.

For more information:

FDA: Office of Oncology Drug Products

http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm091745.htm

FDA: Approved Drugs: Questions and Answers

http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm054420.htm

NCI: Prostate Cancer

http://www.cancer.gov/cancertopics/types/prostate

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

Media Inquiries: Erica Jefferson, 301-
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Updated, Clarified Indication for Use for iFuse Implant System®
2. FDA Approves Lamictal®XR™ (Lamotrigine) for Conversion to Monotherapy for Treatment of Partial Seizures in Appropriate Patients
3. FDA Approves the First Vaccine to Prevent Meningococcal Disease in Infants and Toddlers
4. FDA Approves Actemra to Treat Rare Form of Juvenile Arthritis
5. FDA Approves New Medical Device for Form of Brain Cancer
6. FDA Approves the NovoTTF-100A System for the Treatment of Patients With Recurrent Glioblastoma Multiforme (GBM) Brain Tumors
7. FDA Approves Horizant To Treat Restless Legs Syndrome
8. FDA Approves New Treatment for Rare Form of Thyroid Cancer
9. FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Groups Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma
10. FDA Approves Hyperopia Application for the MEL 80 Excimer Laser from Carl Zeiss Meditec
11. FDA Approves New Treatment for a Type of Late-Stage Skin Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... PUNE, India , August 27, 2015 ... market research reports reviewing the genotyping technology, ... as well as single nucleotide polymorphism (SNP) ... ReportsnReports.com. Complete report on genotyping ... spread across 200 pages, profiling 10 major ...
(Date:8/26/2015)... NEW YORK , Aug. 26, 2015 ... estimated to witness a CAGR of 7.8% during the ... North American ophthalmology cataract surgery devices market in 2014 ... North American ophthalmology cataract surgery devices market is expected ... owing to the increasing strategic expansion of the companies ...
(Date:8/26/2015)... 2015 Edwards Lifesciences Corporation (NYSE: EW ... valves and hemodynamic monitoring, today announced that it has ... privately held company and developer of a transcatheter mitral ... had signed an agreement to acquire CardiAQ. ... $350 million cash for CardiAQ at closing, with an ...
Breaking Medicine Technology:Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 2Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 3Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 4Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 5North America Ophthalmology Cataract Surgery Devices Market by Sub-Market, by End-User - Analysis and Forecast to 2019 2North America Ophthalmology Cataract Surgery Devices Market by Sub-Market, by End-User - Analysis and Forecast to 2019 3Edwards Lifesciences Corporation Completes Acquisition Of CardiAQ 2
(Date:8/27/2015)... ... 27, 2015 , ... Infocast is pleased to announce the ... San Jose, CA. The first event dedicated to finding alternative solutions for ... where battery development and energy storage innovation are concerned. Product developers, designers, ...
(Date:8/27/2015)... Miami, FL (PRWEB) , ... August 27, 2015 ... ... to announce its partnership with Julia Glushko, professional Tennis player for Israel in ... and uses Zensah® Compression for all her training and recovery. , With a ...
(Date:8/27/2015)... ... 2015 , ... Banc Intranets recently entered into a strategic partnership ... Johnson City, Tenn.-based firms to work synergistically to promote similar products to the same ... to organizations in the financial, commercial and services sectors. The software, which is sold ...
(Date:8/27/2015)... (PRWEB) , ... August 27, ... ... Black Swan Analysis signed a partnership agreement for quality market research promotion ... reports elaborated by Black Swan Analysis. , Commenting on the partnership agreement, ...
(Date:8/27/2015)... ... August 27, 2015 , ... King Kullen, America’s First Supermarket, is celebrating ... J. Cullen in 1930 and recognized by the Smithsonian Institute as America’s First Supermarket, ... and operated, the Cullen & Kennedy families have created a culture of caring while ...
Breaking Medicine News(10 mins):Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 2Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 3Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 2Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 3Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 4Health News:Market Publishers Ltd and Black Swan Analysis Sign Partnership Agreement 2Health News:Market Publishers Ltd and Black Swan Analysis Sign Partnership Agreement 3Health News:King Kullen Honors Their 85 Years of Success this August 2
... Exercise experts at the University of Alabama suggest turning back ... increases of activity could prevent over half of new cases ... death from heart disease. ,Exercise physiologist Dr. Gary ... our modern way of life as being the major cause ...
... new study shows that women with a specific ... when they take oestrogen.// Previous research suggests that hormone ... Now doctors at Forest University have discovered a strong ... to HRT. ,An analysis of over 300 women ...
... the increasing number of partial-liver transplants from living donors, ... to certify hospital units to do the surgery.// According ... in New York, which was woefully inadequate post-surgical care, ... of his liver to his brother. ,In their ...
... and Drug Administration announced that Vioxx - Merck's blockbuster ... FDA said that Merck can claim that Vioxx has ... naproxen. But the FDA also decided that the Vioxx ... an increased risk of heart attack or high blood ...
... study, Vitamin C and E supplements protect the coronary ... be a life-saver// but, the vessels linking the new ... only a way could be found of blocking this ... Hopkins Hospital in Boston, US, believe that they have ...
... a chronic neurological disorder in which misfiring electrical impulses ... Americans have epilepsy, and more than a million are ... significant risk that their children will have problems ranging ... study adds to growing evidence that many commonly prescribed ...
Cached Medicine News:
Enhances the eye color of light-eyed patients....
Expressions Accents contact lenses let you enhance your eyes natural color while enjoying incredible comfort and outstanding vision quality....
Modern, innovative and quick Intense Pulsed Light system. The Flash 1 is light and very compact, thus easily portable. Available in two different colors....
... Vasculight SR improves the appearance of photo-aged ... benign brown pigments, telangiectasias, and broken capillaries. ... pulsed light (IPLTM) treats pigmentary sun damage ... combined approach of IPL and the Nd:YAG ...
Medicine Products: